{"id":"NCT01539642","sponsor":"Talphera, Inc","briefTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-02","primaryCompletion":"2013-01","completion":"2013-02","firstPosted":"2012-02-27","resultsPosted":"2014-02-03","lastUpdate":"2015-10-20"},"enrollment":172,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Post-Operative Pain"],"interventions":[{"type":"DRUG","name":"Sufentanil NanoTab PCA System/15 mcg","otherNames":["sufentanil sublingual microtablet system","Zalviso™"]},{"type":"DRUG","name":"Placebo Sufentanil NanoTab PCA System","otherNames":[]}],"arms":[{"label":"Sufentanil NanoTab PCA System/15 mcg","type":"EXPERIMENTAL"},{"label":"Placebo Sufentanil NanoTab PCA System","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy and safety of the Sufentanil NanoTab PCA System/15 mcg to the Placebo Sufentanil NanoTab PCA System for the management of acute moderate to severe post-operative pain after open abdominal surgery.","primaryOutcome":{"measure":"Time-weighted Summed Pain Intensity Difference (SPID) Over the 48-hour Study Period (SPID-48).","timeFrame":"48 hours","effectByArm":[{"arm":"Sufentanil NanoTab PCA System/15 mcg","deltaMin":105.6,"sd":10.14},{"arm":"Placebo Sufentanil NanoTab PCA System","deltaMin":55.58,"sd":13.11}],"pValues":[{"comp":"OG000 vs OG001","p":"0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":12,"countries":["United States"]},"refs":{"pmids":["25318408"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":114},"commonTop":["Nausea","Vomiting","Oxygen Saturation Decreased","Pruritus","Dizziness"]}}